A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral Contraceptives

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Oral Contraceptives

Interventions

DRUG

AZD1981

4X100 mg per oral, twice daily for 28 days

DRUG

Neovletta 21/28

Once daily with (21) or without (28) pause for bleeding.

DRUG

Placebo AZD1981

4X100 mg per oral, twice daily for 28 days

Trial Locations (2)

Research Site, Luleå

Research Site, Uppsala